Home Blog Page 15

OceanX Summit brings leading ocean voices together to connect discovery with impact

In Singapore, global leaders in ocean science, exploration and conservation examine how evidence, storytelling and education can help shape the ocean’s future

SINGAPORE – Media OutReach Newswire – 19 October 2026 – What does it take to turn ocean discovery into lasting change? That question connected three days of conversations at the OceanX Summit 2026, where leaders from ocean science, government, exploration, education and conservation considered how evidence can inform protection, how immersive learning can engage the next generation, and how local leadership can shape solutions.

The Summit brought together oceanographer Sylvia Earle; filmmaker and deep-sea explorer James Cameron; Jill Tiefenthaler, CEO of the National Geographic Society; Takashi Kudo of international art collective teamLab; Benoît Dageville, Co-Founder and President of Products at Snowflake; Rizza Sacra-Dejucos, Asia Regional Coordinator of the High Seas Alliance; Professor Peter Ng of NUS; and conservation leaders Titouan Bernicot of Coral Gardeners and Rili Joani-Mohamed of the Coral Triangle Centre. Singapore Deputy Prime Minister and Minister for Energy, Trade and Industry (Trade) Gan Kim Yong opened the Summit, with Minister for Education Desmond Lee later addressing the role of ocean exploration in student learning.

A clear message emerged: ocean knowledge has its greatest value when it can be shared, understood and used. Discussions on artificial intelligence highlighted both its potential to connect fragmented datasets and its dependence on high-quality information from regions that remain underrepresented. Sessions on finance and marine protected areas explored how public policy, private-sector expertise and philanthropic support can work together, with the needs of coastal communities in view.

“The Summit brought the ocean into the room in a way people could experience. Immersive education can turn curiosity into a personal connection, and help students see how their skills can contribute to ocean science and its future. We need to open those experiences and career pathways to more young people,” said Mark Dalio.

Science that can inform action

The programme connected scientific discovery with the international effort to conserve marine biodiversity beyond national jurisdiction. The Into the Deep: Monsoon Rise expedition, jointly led by OceanX and NUS, mapped more than 8,300 square kilometres of seafloor in the eastern Indian Ocean. Scientists from Southeast Asia and the Pacific worked alongside Singapore researchers, with approximately 2,000 specimens now contributing to continuing biodiversity research.

The Summit also explored the wider challenge of making ocean data useful across disciplines and regions, as countries implement the BBNJ Agreement. OceanX has committed a significant share of its 2027 expedition time to high seas research.

“The Summit made clear that there is a need to collect much more ocean data which is necessary to make informed decisions around ocean stewardship. We need to connect information across disciplines, close gaps in what is known, and make evidence accessible to people working on decision making. Science must work in collaboration with all stakeholders to move together if knowledge is to support lasting ocean protection,” said Vincent Pieribone.

Education and storytelling bring the ocean closer

Singapore’s partnership with OceanX through the Ministry of Education and Science Centre Board has enabled more than 570 students and educators to visit OceanXplorer since 2024, while hundreds more have joined ship-to-shore expedition livestreams. At the Summit, Desmond Lee spoke about how experiences like these help students connect classroom learning to real research and see how skills in engineering, data science and communications contribute to scientific discovery.

The Summit also featured more than 20 immersive installations developed by OceanX Education and its Changemaker community. These experiences put audiences inside ocean stories and research, demonstrating how art, media and technology can build understanding and invite people into the work.

A discussion between Mark Dalio and Anderson Tanoto of Tanoto Foundation highlighted education pathways across Southeast Asia. Nine Tanoto Foundation scholars have participated in OceanX’s Young Explorers programme, while the partnership continues to develop opportunities through fellowships, hackathons and other immersive learning experiences.

Local leadership turns ambition into practice

Speakers from across the conservation community showed how ocean protection is already being advanced by local leaders. Coral Gardeners founder Titouan Bernicot described an island-led movement that has grown to 97 full-time employees and planted more than 250,000 corals across French Polynesia, Fiji and Thailand. Other changemakers presented projects using AI for reef monitoring and immersive media to connect audiences with marine ecosystems.

These examples brought the Summit’s discussions back to people and places: local knowledge must shape conservation, and communities need a meaningful voice in decisions affecting their ocean. The Summit convened more than 750+ participants, including 223 students and educators, around the relationships and ideas that can carry this work forward.

Watch OceanX Summit 2026 highlights.
Hashtag: #OceanX

The issuer is solely responsible for the content of this announcement.

About OceanX

OceanX is a nonprofit working to unlock the ocean’s sustainable potential. Through a dual focus on science and education, we’re building a new paradigm where humanity and the ocean mutually thrive. Our approach is fueled by exploration, leveraging advanced research, multimedia educational programs, cross-sector partnerships, and advanced technology to transform how people understand and value the ocean. Our work strives to fortify biodiversity and increase the sustainable use of ocean resources to help ensure the ocean remains a foundation for human wellbeing and future potential. OceanX is a nonprofit operating program of Dalio Philanthropies. For more information, visit and follow OceanX on , , , and .

OceanX Summit brings leading ocean voices together to connect discovery with impact

In Singapore, global leaders in ocean science, exploration and conservation examine how evidence, storytelling and education can help shape the ocean’s future


SINGAPORE – Media OutReach Newswire – 19 October 2026 – What does it take to turn ocean discovery into lasting change? That question connected three days of conversations at the OceanX Summit 2026, where leaders from ocean science, government, exploration, education and conservation considered how evidence can inform protection, how immersive learning can engage the next generation, and how local leadership can shape solutions.

The Summit brought together oceanographer Sylvia Earle; filmmaker and deep-sea explorer James Cameron; Jill Tiefenthaler, CEO of the National Geographic Society; Takashi Kudo of international art collective teamLab; Benoît Dageville, Co-Founder and President of Products at Snowflake; Rizza Sacra-Dejucos, Asia Regional Coordinator of the High Seas Alliance; Professor Peter Ng of NUS; and conservation leaders Titouan Bernicot of Coral Gardeners and Rili Joani-Mohamed of the Coral Triangle Centre. Singapore Deputy Prime Minister and Minister for Energy, Trade and Industry (Trade) Gan Kim Yong opened the Summit, with Minister for Education Desmond Lee later addressing the role of ocean exploration in student learning.

A clear message emerged: ocean knowledge has its greatest value when it can be shared, understood and used. Discussions on artificial intelligence highlighted both its potential to connect fragmented datasets and its dependence on high-quality information from regions that remain underrepresented. Sessions on finance and marine protected areas explored how public policy, private-sector expertise and philanthropic support can work together, with the needs of coastal communities in view.

“The Summit brought the ocean into the room in a way people could experience. Immersive education can turn curiosity into a personal connection, and help students see how their skills can contribute to ocean science and its future. We need to open those experiences and career pathways to more young people,” said Mark Dalio.

Science that can inform action

The programme connected scientific discovery with the international effort to conserve marine biodiversity beyond national jurisdiction. The Into the Deep: Monsoon Rise expedition, jointly led by OceanX and NUS, mapped more than 8,300 square kilometres of seafloor in the eastern Indian Ocean. Scientists from Southeast Asia and the Pacific worked alongside Singapore researchers, with approximately 2,000 specimens now contributing to continuing biodiversity research.

The Summit also explored the wider challenge of making ocean data useful across disciplines and regions, as countries implement the BBNJ Agreement. OceanX has committed a significant share of its 2027 expedition time to high seas research.

“The Summit made clear that there is a need to collect much more ocean data which is necessary to make informed decisions around ocean stewardship. We need to connect information across disciplines, close gaps in what is known, and make evidence accessible to people working on decision making. Science must work in collaboration with all stakeholders to move together if knowledge is to support lasting ocean protection,” said Vincent Pieribone.

Education and storytelling bring the ocean closer

Singapore’s partnership with OceanX through the Ministry of Education and Science Centre Board has enabled more than 570 students and educators to visit OceanXplorer since 2024, while hundreds more have joined ship-to-shore expedition livestreams. At the Summit, Desmond Lee spoke about how experiences like these help students connect classroom learning to real research and see how skills in engineering, data science and communications contribute to scientific discovery.

The Summit also featured more than 20 immersive installations developed by OceanX Education and its Changemaker community. These experiences put audiences inside ocean stories and research, demonstrating how art, media and technology can build understanding and invite people into the work.

A discussion between Mark Dalio and Anderson Tanoto of Tanoto Foundation highlighted education pathways across Southeast Asia. Nine Tanoto Foundation scholars have participated in OceanX’s Young Explorers programme, while the partnership continues to develop opportunities through fellowships, hackathons and other immersive learning experiences.

Local leadership turns ambition into practice

Speakers from across the conservation community showed how ocean protection is already being advanced by local leaders. Coral Gardeners founder Titouan Bernicot described an island-led movement that has grown to 97 full-time employees and planted more than 250,000 corals across French Polynesia, Fiji and Thailand. Other changemakers presented projects using AI for reef monitoring and immersive media to connect audiences with marine ecosystems.

These examples brought the Summit’s discussions back to people and places: local knowledge must shape conservation, and communities need a meaningful voice in decisions affecting their ocean. The Summit convened more than 750+ participants, including 223 students and educators, around the relationships and ideas that can carry this work forward.

Watch OceanX Summit 2026 highlights.

Hashtag: #OceanX

The issuer is solely responsible for the content of this announcement.

About OceanX

OceanX is a nonprofit working to unlock the ocean’s sustainable potential. Through a dual focus on science and education, we’re building a new paradigm where humanity and the ocean mutually thrive. Our approach is fueled by exploration, leveraging advanced research, multimedia educational programs, cross-sector partnerships, and advanced technology to transform how people understand and value the ocean. Our work strives to fortify biodiversity and increase the sustainable use of ocean resources to help ensure the ocean remains a foundation for human wellbeing and future potential. OceanX is a nonprofit operating program of Dalio Philanthropies. For more information, visit and follow OceanX on , , , and .

Chinese medicine maker addresses global TCM gathering, bringing flagship heart pill to trial in Singapore


SINGAPORE – Media OutReach Newswire – 19 October 2026 – A leading Chinese medicine maker told a global gathering of traditional Chinese medicine (TCM) practitioners here Saturday that a 500-year-old tradition built on treating the whole patient and tailoring treatment has offered an Eastern answer to aging societies and chronic disease worldwide.

Wang Lei, chairman of Da Ren Tang and president of Tianjin Pharmaceutical Group, addresses the congress.
Wang Lei, chairman of Da Ren Tang and president of Tianjin Pharmaceutical Group, addresses the congress.

According to a press report issued by China News Service (CNS), Tianjin Pharmaceutical Da Ren Tang Group, one of China’s oldest pharmacy houses, also announced that it would conduct an international randomized, double-blind, controlled trial of its flagship heart remedy, sold in English as Suxiao Jiuxin Pills, in collaboration with Singapore General Hospital, the city-state’s largest acute tertiary hospital.

https://www.youtube.com/watch?v=W0ac_rOwMNM

Wang Lei, chairman of Da Ren Tang and president of Tianjin Pharmaceutical Group, made both points in her address at the opening ceremony of the 23rd World Congress of Chinese Medicine in Singapore. She noted that Chinese medicine’s holistic approach and pattern-based diagnosis give it an advantage in strengthening public health systems, and that the industry must demonstrate this through internationally recognized, verifiable evidence, the CNS report said.

The study marks the first time a Chinese proprietary medicine has undergone clinical trials at a major Western-medicine hospital in Singapore, the CNS report highlighted.

“We have always believed that Chinese medicine cannot stop at product exports,” Wang said, adding that the trial would offer internationally recognized and verifiable clinical evidence.

The congress, hosted by the World Federation of Chinese Medicine Societies and organized by the Singapore Chinese Physicians’ Association, ran Oct. 16-18 at Raffles City Convention Centre under the theme “Addressing Global Health Challenges, Integrating Chinese Medicine into National Health Systems.” About 1,400 experts, officials and industry representatives from 25 countries and regions participated, the CNS report added.

Wang devoted much of her speech, titled “Gathering the Wisdom of Traditional Medicine to Shoulder the Global Mission of Health,” to arguing that traditional medicine belongs in the global public health conversation rather than on its margins.

Chinese medicine’s emphasis on the body as a whole, and on tailoring treatment to individual patients’ symptom patterns, gives it a distinct advantage in strengthening public health systems, she noted.

For countries facing aging populations and a rising burden of chronic disease, TCM represents “a valuable solution with Eastern characteristics,” Wang said, highlighting its contribution to China’s “Health Silk Road” vision and its role in China’s broader approach to global health governance.

Wang said Da Ren Tang’s roughly 70 years of exporting, dating back to 1955, had taught the company that a remedy must suit the actual health needs of the people who take it rather than be shipped abroad merely as a cultural product.

She set out a three-part plan: concentrate clinical research on cardiovascular and cerebrovascular diseases, respiratory conditions, digestive health, musculoskeletal disorders and skin diseases, working with overseas medical institutions to turn traditional experience into evidence regulators can evaluate; follow international research norms while pursuing product registrations and high-quality studies abroad; and recognize that medical systems and regulatory cultures differ from country to country.

“We have to respect the medical systems and cultural contexts of each country and build an open, mutually trusting and mutually beneficial form of cooperation,” Wang was quoted as saying by CNS.

According to the CNS report, the company is working with Singapore General Hospital on the study and hopes that solid results will help traditional medicine enter national health systems and reach more patients overseas.

Wang called on the congress to bring Chinese medicine standards into alignment with international rules, build platforms for sharing research results, and tell the story of Chinese medicine to the world.

Da Ren Tang traces its pharmacy lineage to 1522 and has been listed in Singapore since 1997. The company holds 122 exclusive products and 599 drug approval numbers, sells more than 150 products in more than 20 countries, and ranks among China’s top five exporters of traditional Chinese medicine, according to the CNS report.
Hashtag: #ChinaNewsService

The issuer is solely responsible for the content of this announcement.

Eureka Introduces FloorShine 470, Bringing All-Round Wet-and-Dry Cleaning to French Homes


PARIS, FRANCE – Media OutReach Newswire – 19 October 2026 – Eureka has introduced the FloorShine 470 to the French market, combining wet-and-dry floor cleaning, access beneath low furniture and automated brush care in one appliance. Designed for everyday hard-floor maintenance, the model brings together practical features intended to make regular cleaning simpler and more convenient.

Eureka

As floor-cleaning appliances become increasingly sophisticated, more features do not necessarily mean a better fit for every household. Everyday cleaning still comes down to familiar needs: dealing with spills, removing dust and hair, and reaching areas that are often overlooked. The FloorShine 470 addresses these tasks through a balanced combination of cleaning performance and ease of use, with a recommended retail price of €279.

With up to 17,000 Pa of suction, the FloorShine 470 combines vacuuming and washing to handle dry debris and liquid spills in a single cleaning routine. Whether collecting crumbs after a meal or removing dirt brought in from outdoors, the appliance is designed to support regular floor care. Its integrated anti-tangle mechanism also helps reduce hair wrapping around the brush roller.

Reaching difficult areas is another consideration in everyday cleaning. The 180-degree lie-flat design allows the FloorShine 470 to clean beneath sofas, beds and other low-clearance furniture. An internal water duct helps prevent wastewater backflow when the appliance is reclined, while the edge-cleaning brush reaches close to walls and skirting boards.

Maintenance has also been considered in the design. After cleaning, an automated self-cleaning and hot-air drying system helps remove residue and moisture from the brush roller, reducing the need for manual upkeep. A redesigned water-tank configuration supports comfortable maneuvering, while separate clean- and dirty-water tanks simplify routine use.

Rather than relying on increasingly complex features, the FloorShine 470 brings together essential cleaning and maintenance functions in an accessible, all-round wet-and-dry cleaner.

Pricing and Availability

The Eureka FloorShine 470 is now available in France through the official Eureka website, with a recommended retail price of €279. Prices and promotional offers may vary, and the model can also be found by searching for “Eureka FloorShine 470” on Amazon.

Hashtag: #Eureka

The issuer is solely responsible for the content of this announcement.

About Eureka

Eureka develops household cleaning appliances designed to simplify everyday maintenance. Its portfolio includes cordless vacuum cleaners, robotic cleaners and wet-and-dry floor washers for international markets.

Three in Four Singaporeans Say Their Spare Cash Isn’t Working Hard Enough

Only 1 in 10 are very confident they know the interest rate their bank accounts pay


SINGAPORE – Media OutReach Newswire – 19 October 2026 – Three in four Singaporeans with spare cash do not believe it is working as hard as it could, according to new research commissioned by Chocolate Finance and conducted by independent research company Milieu. That uncertainty also extends to what the money is actually for: seven in ten have no plan for when they will use it.

3 in 4 Singaporeans don't believe their spare cash is working as hard as it can.

The survey of 1,000 Singapore residents found that 89% of respondents hold spare cash. Among them, nearly half (48%) had looked at their cashback or reward points in the past six months, compared with 37% who checked the interest rate on their spare cash. CPF balances and discounts, vouchers or promo codes also received more attention than spare cash rates.

The findings point to an attention gap. Singaporeans are actively looking for value in the money they spend, but what their spare cash earns can receive less scrutiny and attention, once that money has been set aside.

“We’ve always known that Singaporeans want more from their spare cash. What this research proves is just how many people don’t actually know what their money is earning. People move their money around for an attractive welcome offer, but once that offer ends, the money often just sits there, earning very little. And many don’t even realise it. We created Chocolate Finance to change that,” said Walter de Oude, Founder and CEO of Chocolate Finance.

Visible rewards are winning more attention
Part of the difference comes down to visibility. Cashback, rewards and discounts provide an immediate and obvious benefit, whether at checkout, when points appear in an account, or in monthly statements. The return on spare cash, however, is less visible and can happen quietly in the background.

This makes it easier for a few dollars saved on a purchase to command more attention, while the return on a much larger pool of cash receives less scrutiny. The result is not a lack of financial engagement, but an imbalance in where that attention is going.

More financial choice makes clarity more important
Keeping track of spare cash can become harder when that money is spread across several places. Singaporeans use an average of 3.7 named banks and financial platforms, spanning traditional banks, digital banks and wealth or cash-management platforms.

Only 1 in 10 are very confident they know the interest rate their bank accounts pay.

Whilst more financial options can create greater choice, the findings suggest that simply having more places to put money does not necessarily make that money easier to understand. Only one in ten respondents (11%) are very confident they know the interest rate their bank accounts pay, with the majority 89% indicating that they are not fully confident.

When money is spread across several providers and people are unclear about what those accounts are paying, individual pools of spare cash can become easier to lose sight of how each fits into a bigger picture. This raises the question: beyond knowing where the money sits, do people know what they actually want that money to do?

Giving spare cash a purpose can change behaviour
For many Singaporeans, that purpose is not clear yet. Some 72% of spare cash holders either describe it as money for “one day, eventually” or do not think about timing at all, while only 29% of respondents separate all their money into clear categories for different purposes.

Giving the money a specific goal could change that behaviour. When asked how they would behave if they could separate their spare cash into categories for specific goals, 59% said they would be more likely to leave it untouched and let it grow.

That insight is behind Chocolate Finance’s new Jars feature, launching in November 2026. Jars allow customers to separate their spare cash into different ‘pots’ for goals such as an emergency fund, a holiday or a home. Instead of treating spare cash as one pool, each Jar gives the money a clearer purpose and timeframe.

Walter added: “What really stands out is that Singaporeans are already putting money aside, but many don’t have a clear plan for what that money is for. And when people give their spare cash a purpose, they’re more likely to leave it alone and let it grow. That’s a really important insight, and exactly why we’re launching Jars. We want to make it easier for people to turn their spare cash into something they’re actually working towards.”

Saving money is only the first step
Taken together, the findings point to a gap between actively saving money and deciding what happens to it next. Once money has been set aside, it can become less visible, spread across different providers and disconnected from a clear goal. The common thread is clarity: knowing what each pool of spare cash is for and what it needs to do.

This does not mean every dollar should chase the highest possible return. It means making a deliberate decision about the role of that money, rather than letting spare cash become something that has simply been saved and then forgotten.

Conclusively, Singaporeans who already have money set aside should be asking themselves not “how much have I saved” but rather “Is this money doing the job I need it to do?”
Hashtag: #ChocolateFinance #SpareCash





The issuer is solely responsible for the content of this announcement.

Chocolate Finance

Methodology
The online survey was conducted by independent research company Milieu from 25 September 2026 to 5 October 2026 among n=1,000 Singapore residents aged 18 and above. The results carry a margin of error of +/- 3% at a 95% confidence level.

About Chocolate Finance
Chocolate Finance was founded in 2024 and operates as a licensed fund management company offering cash management, savings and payment solutions in Singapore. The Chocolate Finance platform helps people grow their spare cash every day, no lock-ins, no complex rules. Customers can see their returns on the app every single day – simple account setup and the flexibility to spend through their linked Visa card and hold investments in SGD or USD.

For more information, please visit:

Disclaimer
Chocolate Finance is a brand of Chocfin Pte Ltd and is regulated by the Monetary Authority of Singapore. Terms and conditions apply.

Please visit to learn more. Chocolate’s returns are subject to change based on market conditions, with Chocolate top-up support offered as an incentive during the Qualifying Period. All investments involve risk, including the risk of losing all of the invested amount and may not be suitable for everyone. Past performance is not indicative of future results. This advertisement has not been reviewed by the Monetary Authority of Singapore.

OncoC4 Announces NMPA Acceptance of Two IND Applications for Cesalatamig Combination Studies with ADCs and Pan-RAS Inhibitors

— New Studies Expand Cesalatamig into Biomarker-driven Precision

Immuno-oncology Strategies

— Cesalatamig is Also Being Evaluated in Ongoing Phase 2 Studies in

the United States and in China

ROCKVILLE, Md. , Oct. 19, 2026 /PRNewswire/ — OncoC4 Inc., a late clinical-stage biopharmaceutical company developing novel medicines for cancer and neurodegenerative diseases, today announced that the China National Medical Products Administration (NMPA) has accepted two new Investigational New Drug (IND) applications (CXSL2601129 and CXSL2601130) to evaluate cesalatamig (AI-081), the company’s differentiated PD-1/VEGF bispecific antibody, in novel combination regimens for patients with advanced solid tumors.

The INDs will support clinical studies evaluating cesalatamig in combination with antibody-drug conjugates (ADCs) across selected solid tumors and with pan-RAS inhibitors in molecularly defined patient populations.

The studies represent an important expansion of OncoC4’s strategy to establish cesalatamig as a foundational immuno-oncology backbone with the potential to enhance activity across multiple therapeutic modalities.

“The acceptance of these new IND applications in China marks an important milestone in the evolution of our cesalatamig development strategy,” said Dr. Pan Zheng, Co-founder and Chief Medical Officer of OncoC4. “We believe the dual targeting of PD-1 and VEGF may provide a highly complementary platform for combination approaches. By integrating cesalatamig with next-generation ADCs and precision oncology therapies such as RAS pathway inhibitors, we aim to unlock new treatment options for patients whose cancers remain difficult to treat with current standards of care.”

Cesalatamig is designed to simultaneously inhibit tumor angiogenesis and enhance anti-tumor immune responses through dual blockade of VEGF and PD-1. OncoC4 is evaluating cesalatamig across multiple tumor types in ongoing clinical studies in the United States and China. In September 2026, cesalatamig received U.S. FDA Fast Track Designation for non-small cell lung cancer (NSCLC) that progressed after concurrent or sequential PD-(L)1-targeted immunotherapy and platinum-based chemotherapy.

The ADC combination program is intended to evaluate the potential for cesalatamig to enhance anti-tumor activity through complementary mechanisms of action, leveraging the targeted cytotoxic activity of ADCs together with immune activation and vascular normalization associated with dual PD-1/VEGF blockade.

The precision medicine program will evaluate cesalatamig in combination with inhibitors of the RAS signaling pathway, one of the most frequently dysregulated oncogenic pathways across solid tumors1-2.  These studies will assess whether concurrently targeting tumor-intrinsic signaling and the tumor microenvironment can produce deeper and more durable clinical responses in biomarker-selected patient populations.

“Having obtained clinical proof-of-concept data demonstrating the activity of cesalatamig monotherapy in several challenging cancer indications, as well as its combinability with chemotherapy, we are now advancing rational combinations with precision therapies,” said Dr. Yang Liu, Co-founder, Chief Executive Officer and Chief Scientific Officer of OncoC4. “These INDs expand our ability to evaluate cesalatamig in high-priority combinations and advance our vision of precision immuno-oncology.”

Patient enrollment is expected to begin following NMPA approval and completion of site activation activities.

About Cesalatamig

Cesalatamig (AI-081) is a differentiated PD-1/VEGF bispecific antibody designed to promote stronger cooperative interaction between PD-1 and VEGF blockade through high affinity to PD-1 and substantially higher VEGF-binding affinity than bevacizumab-based PD-(L)1/VEGF bispecific antibodies. As a result, cesalatamig shows best-in-class potential that favors its action in a PD-1 and VEGF-rich tumor microenvironment. Cesalatamig also has more effective Fc-silencing modifications to avoid the depletion of PD-1-positive effector T cells. The U.S. FDA granted cesalatamig Fast Track Designation for the treatment of non-small cell lung cancer (NSCLC) that progressed after concurrent or sequential PD-(L)1-targeted immunotherapy and platinum-based chemotherapy in September 2026.

About OncoC4

Headquartered in Rockville, Maryland, OncoC4 is a privately held, late clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel biologics for the treatment of cancer and neurodegenerative diseases. OncoC4’s pipeline features assets with first-in-class and best-in-class potential targeting both novel and well-validated targets across oncology and immunological diseases, including neurodegenerative diseases. Among them, cesalatamig is a wholly owned and highly differentiated PD-1/VEGF bispecific antibody currently undergoing rapid global clinical development in multiple oncology indications. Tasafustobart (ONC-841) is a first-in-class anti-SIGLEC-10 antibody currently in a Phase 2 trial for oncology indications and a Phase 1 trial for neurodegenerative diseases. In addition, OncoC4 recently initiated a first-in-human trial of ONC-783, a first-in-class T cell engager targeting a novel CD24 epitope selectively expressed across a broad spectrum of human cancers, including solid tumors and hematological malignancies, in the United States. OncoC4 has a strategic collaboration with BioNTech to co-develop gotistobart (BNT316/ONC-392), a tumor microenvironment-selective Treg depletion candidate targeting CTLA-4, in multiple solid tumor indications, including an ongoing pivotal clinical trial in squamous non-small cell lung cancer.

More information: www.oncoc4.com

CONTACTS

Media Relations
Helen Schiltz
media@oncoc4.com

Investor Relations
Ryan Cui
ir@oncoc4.com

References

1. Yang X, Wu H. RAS signaling in carcinogenesis, cancer therapy and resistance mechanisms. J Hematol Oncol. 2024;17:108. doi: 10.1186/s13045-024-01631-9.

2. Stites EC. The abundance of KRAS and RAS gene mutations in cancer. Methods Mol Biol. 2024;2797:13–22. doi: 10.1007/978-1-0716-3822-4_2.

Julia Gillard joins Hakluyt’s International Advisory Board

LONDON, Oct. 19, 2026 /PRNewswire/ — Hakluyt, the global strategic advisory firm for businesses and investors, is delighted to announce the appointment of The Honourable Julia Gillard AC, former prime minister of Australia and current chair of Wellcome, to its international advisory board.

Julia Gillard
Julia Gillard

Julia Gillard is one of Australia’s most prominent political leaders and an influential figure in global health. She began her career at the law firm Slater & Gordon, where she became a partner, before moving into politics as chief of staff to the premier of Victoria. Elected to the Australian House of Representatives in 1998, Julia served as deputy prime minister from 2007 to 2010, and then as prime minister of Australia from 2010 to 2013 – the first woman to hold the role.

Julia currently serves as chair of Wellcome, the UK-based global charitable foundation focused on improving health through science. She is also patron of the Campaign for Female Education (CAMFED), the inaugural chair of the Global Institute for Women’s Leadership at King’s College London, and patron of Beyond Blue, a mental health charity in Australia.

Chaired by Lord William Hague, Hakluyt’s international advisory board includes senior leaders from across business, government and academia, who support the firm’s global connectivity and expertise.

Lord Hague said: “I am delighted to welcome Julia to Hakluyt’s international advisory board. She brings first-hand experience of government decision-making that will be of great value to the firm, and her work at Wellcome gives her a global perspective on science, innovation and health, as well as the partnerships needed to tackle some of the world’s most pressing challenges.”

Julia Gillard commented: “I am excited to be joining Hakluyt’s international advisory board. Having had the privilege of serving in public office at the highest level, I have seen how critical sound judgement is in periods of uncertainty and change. I look forward to working with William and my fellow advisory board members to support Hakluyt’s clients and the firm’s continued growth.”

Thomas Ellis, Hakluyt’s managing partner, added: “I am thrilled that Julia is joining Hakluyt’s international advisory board. She combines exceptional government experience with a deep understanding of the forces shaping economies and societies around the world. As a highly respected voice on leadership questions and many global trends and issues, she brings a distinctive perspective that will strengthen the advice we provide to our clients.”

This appointment is effective immediately.

Notes to editors:
Hakluyt is a strategic advisory firm that works with corporate leaders and investors around the world on their most important commercial issues. For more information on the firm, please visit www.hakluytandco.com

2026 Canton Fair Design Award Winners Showcase China’s Innovation Strength

GUANGZHOU, China, Oct. 19, 2026 /PRNewswire/ — As the 140th Canton Fair opens, the winners of the 2026 Canton Fair Design Award (CF Award) have also been announced. Winning products are now on display in Area D of the Canton Fair Complex, offering visitors a closer look at some of the latest advances in Chinese manufacturing and industrial design.

Among this year’s top honorees, a domestically developed high-performance sport motorcycle and an intelligent navigation capsule robot gastric endoscopy system received the Best of the Best Award, the competition’s highest recognition.

The Canton Fair also enhanced the visitor experience with a themed showcase area within the award exhibition. Built around four application-oriented concepts, namely Outdoor Pleasure, Smart Living, Cozy Home and Kitchen Elegance, the immersive displays demonstrate how innovative designs can be integrated into everyday life, helping visitors better understand the practical value behind these award-winning products.

This year, 4,218 products from 2,112 companies competed for the award. Following multiple rounds of evaluation, 222 products from 174 companies were selected.

The award-winning products reflect several key trends shaping the next stage of Chinese manufacturing. Innovation remains a defining theme, with breakthrough technologies ranging from upper limb motor function assistance and enhancement system to exoskeleton robots, underscoring the growing momentum of high-end manufacturing.

Meanwhile, intelligent technologies continue to gain traction across industries. Smart products account for more than 30% of this year’s winners, with AI-powered glasses, intelligent conference terminals and smart healthcare devices extending AI applications across home, office, medical and outdoor environments.

Sustainability is also becoming increasingly embedded throughout the product lifecycle. Green products represent over 40% of the winning entries, while innovations such as integrated energy-saving panels and sugarcane paper demonstrate how environmentally conscious practices are being incorporated into product design, materials selection and manufacturing processes.

Established in 2013, the Canton Fair Design Award is widely regarded as a benchmark for design innovation in China’s foreign trade sector. The award recognizes products that combine design excellence with commercial value, promoting the transformation and upgrading of Chinese manufacturing and supporting high-quality trade development. Entries are evaluated across five dimensions: innovation, quality, functionality, aesthetics and sustainability.

For more convenient attendance, please click here for pre-registration:
https://buyer.cantonfair.org.cn/register/buyer/email?source_type=16

Canton Fair
Canton Fair